Creatine Monohydrate Group
|
Peak Torque % Decline Change
|
Phosphocreatine Disodium Salts Plus Blueberry Extract Group
|
Peak Torque % Decline Change
|
Placebo Group
|
Peak Torque % Decline Change
|
---|
1
|
0.11
|
1
|
8.58
|
1
|
4.24
|
2
|
1.97
|
2
|
9.56
|
2
|
12.63
|
3
|
0.91
|
3
|
−29.01a
|
3
|
11.90
|
4
|
4.07
|
4
|
9.55
|
4
|
−26.67a
|
5
|
−20.67a
|
5
|
16.40
|
5
|
−0.99
|
6
|
2.75
|
6
|
55.55
|
6
|
−10.81a
|
7
|
−38.48a
|
7
|
−1.11
|
7
|
9.30
|
8
|
27.34
|
8
|
29.39
|
8
|
−9.62
|
9
|
0.00
|
9
|
8.88
|
9
|
0.81
|
10
|
7.75
|
10
|
9.37
|
10
|
26.07
|
11
|
10.53
|
11
|
−2.38
| | |
12
|
−12.62a
| | | | |
Proportion exceeding the minimal important difference
|
3 of 12 (25%)
| |
1 of 11 (9%)
| |
2 of 10 (20%)
|
- aIndicates a reduction in percent decline for peak torque that exceeded the minimal important difference (pooled pre-supplementation S.D. × 0.5 effect size = −10.77%)